Disease | liver disease |
Phenotype | C0035078|renal failure |
Sentences | 10 |
PubMedID- 22429536 | Hrs is defined as the occurrence of renal failure in patients with advanced liver disease without another identifiable cause of renal failure, and is usually classified into two types according to the definition of the international ascites club [21]. |
PubMedID- 21994871 | Hrs is defined as the development of renal failure in patients with advanced liver disease in the absence of other identifiable causes of renal failure. |
PubMedID- 23409777 | Our data favors the concept that meld score and in turn severity of liver disease correlates with postoperative renal failure and rrt. |
PubMedID- 20616412 | Acute renal failure associated with liver disease is a commonly encountered clinical problem of varied etiology. |
PubMedID- 25233964 | renal failure in patients with end stage liver disease and its impact on clinical outcome. |
PubMedID- 25296092 | An estimated 11% of patients with advanced cirrhosis and refractory ascites develop hrs.1 this condition is traditionally ascribed to functional renal failure in patients with chronic liver disease associated with no significant morphologic changes in renal histology and with largely preserved tubular function.2, 3 this is because kidneys from patients with hrs have been reported to recover function post liver transplantation,4 and they have also been successfully used as renal allografts for kidney transplantation.5 however, only a small proportion of patients who develop renal dysfunction in association with cirrhosis suffer from hrs. |
PubMedID- 25854911 | Usefulness of liver test and controlled attenuation parameter in detection of nonalcoholic fatty liver disease in patients with chronic renal failure and coronary heart disease. |
PubMedID- 24136393 | Hepatitis b (hbv) virus infection is one of the most important causes of liver disease in patients with end-stage renal failure on hemodialysis. |
PubMedID- 23049205 | Hepatorenal syndrome (hrs) is defined as a functional renal failure in patients with liver disease with portal hypertension and it constitutes the climax of systemic circulatory changes associated with portal hypertension. |
PubMedID- 20529577 | Conclusions: slkt is an effective therapy for end-stage liver disease with chronic renal failure or severe damage to renal function. |
Page: 1